Back to results
US 8,138,361 B2Granted
C-10 carbamates of taxanes
AssigneesThe Trustees of the University of Pennsylvania, Acidophil llc
InventorsCarlo Ballatore, Angelo J Castellino, Amos B Smith, III, Joel Desharnais, Chengzao Sun, Simon E Aspland
Life of this patent
Estimating the term…
Abstract
Provided herein are C-10 taxane carbamates and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating cancer and taupathy.
Claims37
A compound of formula 1:
- or pharmaceutically acceptable compound, wherein
- R1 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl or acyl;
- R2 is alkyl or aryl, wherein the aryl group is optionally substituted with one to three electron withdrawing or electron donating groups;
- R7 is H or OR7a where R7a is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, —COR7b, —CONR7cR7d or is hydroxyl protecting group, wherein
- R7b is alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl, and
- R7c and R7b are each independently selected as follows:
- a) R7c and R7d are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl, or
- b) R7c and R7d together with the nitrogen atom form an optionally substituted 5-7 membered heterocyclic or heteroaryl ring;
- R9 is ═O, or —OR7a;
- X is NRxRy, where Rx is hydrogen or alkyl and Ry is carboxyalkyl, carboxyheteroalkyl, carboxyalkenyl, carboxyalkynyl, carboxycycloalkyl, carboxyheterocyclyl, carboxyaryl, carboxyheteroaryl or aminoheteroalkyl,
- wherein the amino group is optionally protected with a protecting group;
- R14 is hydrogen, hydroxyl or alkoxy;
- R3a is alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl;
- R4a is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl or is hydroxyl protecting group;
- R5a is —COR7b, —COOR7b, or CONR7cR7d;
- and
- R1, R2, R3a, R4a, R5a, R7a, R7b, R7c, R7d, Ry, and R14 are unsubstituted or substituted with 1-4 substituents Q1, wherein each Q1 is independently halo, pseudohalo, hydroxy, oxo, thia, nitrile, amino, nitro, formyl, mercapto, hydroxycarbonyl, hydroxycarbonylalkyl, alkyl, haloalkyl, aminoalkyl, diaminoalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocycclylalkyl, aryl, heteroaryl, aralkyl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, aralkyloxycarbonyl, aralkoxycarbonylamino, aminocarbonyl, alkoxy, aryloxy, heteroaryloxy, heteroaralkoxy, heterocyclyloxy, cycloalkoxy, aralkoxy, alkylamino, dialkylamino, haloalkylamino, arylamino, diarylamino or alkylarylamino
- with the proviso that when R1 is hydrogen, R2 is aryl, R3a is aryl, R4a is hydrogen, R5a is —COR7b, R7b is aryl, R7 is —OH, and R9 is ═O, X is NRxRy, and Rx is hydrogen, then Ry is not aminoheteroalkyl.
15 more elements
A compound of formula 1a:
- or pharmaceutically acceptable compound thereof, wherein X is glucosamine, or is NRxRy, where Rx is hydrogen or lower alkyl and Ry is alkyl substituted with one to three substitutents selected from hydroxy, amino, alkylaminocarbonyl, dialkylaminocarbonyl, aralkoxycarbonyl, alkoxycarbonyl, aralkoxycarbonylamino, and heterocyclylaminocarbonyl, wherein the heterocyclyl group contains a 5 to 7 membered ring containing one or two heteroatoms selected from N and O and is optionally substituted with 1 to 4 hydroxy or hydroxyalkyl groups,
- R3a is alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl or phenyl;
- R5a is —COR7b, —COOR7b or —CONHR7b;
- R7b is alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl or aryl;
- and
- R3a, R5a and R7b are unsubstituted or substituted with 1-4 substituents Q1, wherein each Q1 is independently is halo, pseudohalo, hydroxy, amino, nitro, alkyl, haloalkyl, aminoalkyl, diaminoalkyl, cycloalkyl, heterocycly, stryl, heteroaryl, aralkyl, alkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, aralkyloxycarbonyl or aralkoxycarbonylamino
- with the proviso that when R3a is aryl, R5a is —COR7b, R7b is aryl, X is NRxRy, and Rx is hydrogen, then Ry is not aminoheteroalkyl and when R3a is aryl, R5a is —COR7b, and R7b is aryl, X is not gluxosamine.
4 more elements
Dependencies are inferred from the claim text.